221 related articles for article (PubMed ID: 25075768)
1. Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.
Zhang K; Meng X; Li D; Yang J; Kong J; Hao P; Guo T; Zhang M; Zhang Y; Zhang C
Kidney Int; 2015 Feb; 87(2):359-69. PubMed ID: 25075768
[TBL] [Abstract][Full Text] [Related]
2. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
[TBL] [Abstract][Full Text] [Related]
3. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition.
Liu CX; Hu Q; Wang Y; Zhang W; Ma ZY; Feng JB; Wang R; Wang XP; Dong B; Gao F; Zhang MX; Zhang Y
Mol Med; 2011; 17(1-2):59-69. PubMed ID: 20844835
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin blockade attenuates diabetic nephropathy in hypogonadal adult male rats.
Makary S; Abdo M; Hassan WA; Tawfik MK
Can J Physiol Pharmacol; 2019 Aug; 97(8):708-720. PubMed ID: 30970225
[TBL] [Abstract][Full Text] [Related]
6. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.
Kelly DJ; Skinner SL; Gilbert RE; Cox AJ; Cooper ME; Wilkinson-Berka JL
Kidney Int; 2000 May; 57(5):1882-94. PubMed ID: 10792607
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats.
Kim CS; Kim IJ; Bae EH; Ma SK; Lee J; Kim SW
PLoS One; 2015; 10(11):e0142664. PubMed ID: 26556707
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
Lakshmanan AP; Watanabe K; Thandavarayan RA; Sari FR; Harima M; Giridharan VV; Soetikno V; Kodama M; Aizawa Y
Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
[TBL] [Abstract][Full Text] [Related]
9. Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.
Huang J; Matavelli LC; Siragy HM
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):215-21. PubMed ID: 21265872
[TBL] [Abstract][Full Text] [Related]
10. Ameliorative potential of angiotensin1-7/Mas receptor axis in streptozotocin-induced diabetic nephropathy in rats.
Singh T; Singh K; Sharma PL
Methods Find Exp Clin Pharmacol; 2010; 32(1):19-25. PubMed ID: 20383342
[TBL] [Abstract][Full Text] [Related]
11. FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats.
Sanajou D; Ghorbani Haghjo A; Argani H; Roshangar L; Ahmad SNS; Jigheh ZA; Aslani S; Panah F; Rashedi J; Mesgari Abbasi M
J Physiol Biochem; 2018 Aug; 74(3):467-478. PubMed ID: 29948786
[TBL] [Abstract][Full Text] [Related]
12. Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice.
Moon JY; Tanimoto M; Gohda T; Hagiwara S; Yamazaki T; Ohara I; Murakoshi M; Aoki T; Ishikawa Y; Lee SH; Jeong KH; Lee TW; Ihm CG; Lim SJ; Tomino Y
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1271-82. PubMed ID: 21367916
[TBL] [Abstract][Full Text] [Related]
13. Valsartan blocks thrombospondin/transforming growth factor/Smads to inhibit aortic remodeling in diabetic rats.
Sun H; Zhao Y; Bi X; Li S; Su G; Miao Y; Ma X; Zhang Y; Zhang W; Zhong M
Diagn Pathol; 2015 Apr; 10():18. PubMed ID: 25884585
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.
Shi Y; Lo CS; Padda R; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Clin Sci (Lond); 2015 May; 128(10):649-63. PubMed ID: 25495544
[TBL] [Abstract][Full Text] [Related]
15. H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation.
Xue H; Yuan P; Ni J; Li C; Shao D; Liu J; Shen Y; Wang Z; Zhou L; Zhang W; Huang Y; Yu C; Wang R; Lu L
PLoS One; 2013; 8(9):e74366. PubMed ID: 24058553
[TBL] [Abstract][Full Text] [Related]
16. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
[TBL] [Abstract][Full Text] [Related]
17. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
Zhou G; Cheung AK; Liu X; Huang Y
Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.
Hao PP; Yang JM; Zhang MX; Zhang K; Chen YG; Zhang C; Zhang Y
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1007-19. PubMed ID: 25724492
[TBL] [Abstract][Full Text] [Related]
19. KMUP-1 attenuates high glucose and transforming growth factor-β1-induced pro-fibrotic proteins in mesangial cells.
Lin SH; Chen IJ; Chuang CT; Ho WT; Chuang LY; Guh JY
Mol Med Rep; 2017 Jun; 15(6):4199-4206. PubMed ID: 28440482
[TBL] [Abstract][Full Text] [Related]
20. Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression.
Tawfik MK; Keshawy MM; Makary S
Mol Biol Rep; 2021 Sep; 48(9):6457-6470. PubMed ID: 34431038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
